These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31407469)

  • 41. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation Between Symptomatic Gastro-Esophageal Reflux Disease (GERD) and Erosive Esophagitis (EE) Post-vertical Sleeve Gastrectomy (VSG).
    Lim CH; Lee PC; Lim E; Tan J; Chan WH; Tan HC; Ganguly S; Tham KW; Eng A
    Obes Surg; 2019 Jan; 29(1):207-214. PubMed ID: 30238218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis.
    Tokudome K; Funaki Y; Sasaki M; Izawa S; Tamura Y; Iida A; Ogasawara N; Konagaya T; Tokura Y; Kasugai K
    World J Gastroenterol; 2012 Nov; 18(41):5940-7. PubMed ID: 23139611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modern diagnosis of GERD: the Lyon Consensus.
    Gyawali CP; Kahrilas PJ; Savarino E; Zerbib F; Mion F; Smout AJPM; Vaezi M; Sifrim D; Fox MR; Vela MF; Tutuian R; Tack J; Bredenoord AJ; Pandolfino J; Roman S
    Gut; 2018 Jul; 67(7):1351-1362. PubMed ID: 29437910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
    Mahoney LB; Nurko S; Rosen R
    J Pediatr; 2017 Oct; 189():86-91. PubMed ID: 28711175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanisms associated with reflux episodes in ambulant subjects with gastro-esophageal reflux disease.
    Iovino P; Theron B; Prew S; Menon S; Trudgill N
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14023. PubMed ID: 33112052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with complicated erosive esophagitis: A Japanese multicenter, prospective, cross-sectional study.
    Sakaguchi M; Manabe N; Ueki N; Miwa J; Inaba T; Yoshida N; Sakurai K; Nakagawa M; Yamada H; Saito M; Nakada K; Iwakiri K; Joh T; Haruma K
    World J Gastroenterol; 2017 Jan; 23(2):318-327. PubMed ID: 28127205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough.
    Ribolsi M; Luca Guarino MP; Balestrieri P; Altomare A; Tullio A; Petitti T; Cicala M
    Am J Gastroenterol; 2021 Nov; 116(11):2199-2206. PubMed ID: 34287222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal study of gastroesophageal reflux and erosive tooth wear.
    Wilder-Smith CH; Materna A; Martig L; Lussi A
    BMC Gastroenterol; 2017 Oct; 17(1):113. PubMed ID: 29070010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.
    Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M
    United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
    Jain M; Agrawal V
    Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.
    Stern EK; Carlson DA; Falmagne S; Hoffmann AD; Carns M; Pandolfino JE; Hinchcliff M; Brenner DM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 29110377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.
    Vailati C; Mazzoleni G; Testoni PA; Passaretti S
    J Clin Gastroenterol; 2014 Aug; 48(7):613-9. PubMed ID: 24326754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting the treatment outcomes of laparoscopic fundoplication for erosive reflux esophagitis: findings of esophageal pathological function tests.
    Tsuboi K; Yano F; Omura N; Hoshino M; Yamamoto SR; Akimoto S; Masuda T; Sakashita Y; Ikegami T
    Surg Today; 2021 Oct; 51(10):1568-1576. PubMed ID: 33491102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD.
    Ribolsi M; Savarino E; Frazzoni M; Cicala M
    Dig Liver Dis; 2023 Jun; 55(6):721-726. PubMed ID: 36572569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis.
    Adachi K; Fujishiro H; Katsube T; Yuki M; Ono M; Kawamura A; Rumi MA; Watanabe M; Kinoshita Y
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1191-6. PubMed ID: 11903734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Gastroesophageal Reflux Disease 1 Year after Esophageal Atresia Repair: Paradigms Lost from a Single Snapshot?
    Tambucci R; Isoldi S; Angelino G; Torroni F; Faraci S; Rea F; Romeo EF; Caldaro T; Guerra L; Contini ACI; Malamisura M; Federici di Abriola G; Francalanci P; Conforti A; Dall'Oglio L; De Angelis P
    J Pediatr; 2021 Jan; 228():155-163.e1. PubMed ID: 32918920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.